As the derivatives market grows, OTC collateral agreement such as CSA (Credit Support Annex) is widely used to manage credit risks, however the efficiencies of CSA implementation may be compromised by the mismatches lied in the system records between the 2 parties. Portfolio reconciliation was established as a process to verify the accuracy of a firm’s trade population using live system data by comparing the two counterparty’s records of a bi-lateral OTC portfolio as of a given business date.
The industry would like to promote regular portfolio reconciliation in the Asia Pacific region. Under the auspice of ISDA Collateral Steering Committee, ISDA Asia Pacific Collateral Management Operations Working Group launched an initiative to draft a Memorandum of Understanding of Portfolio Reconciliation, the document is published on January 3, 2011. Firms with business in the Asia Pacific region are encouraged to adhere to the MoU.
Documents (3) for Asia Pacific Collateralized Portfolio Reconciliation Memorandum of Understanding (MoU)
Latest
Steps to a Vibrant Derivatives Market: SOM Remarks
Steps to a Vibrant and Resilient Derivatives Market December 4, 2025 Remarks at the Mediterranean Partnership of Securities Regulators Scott O’Malia ISDA Chief Executive Officer Good afternoon and thank you to the Mediterranean Partnership of Securities Regulators (MPSR) for...
ISDA Response to BoE on Gilt Market Resilience
On November 28, ISDA responded to the Bank of England’s discussion paper on gilt market resilience. ISDA encourages the Bank of England, before introducing any significant policy changes that would affect the functioning of the gilt repo market, to consider...
Addressing Termination Troubles
When Enron announced a shock $618 million loss on October 16, 2001, it took a further 47 days until it filed for bankruptcy. For Bear Stearns, it took 266 days between its bailout of a structured credit fund run by...
ISDA In Review – November 2025
A compendium of links to new documents, research papers, press releases and comment letters published by ISDA in November 2025.